192 related articles for article (PubMed ID: 36421335)
1. High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma.
Xu W; Huang Y; Mei Y; Zhang Y; Luo Q; Zhu S; Peng L; Gao Z; Liu Y; Li J
Curr Oncol; 2022 Nov; 29(11):8650-8667. PubMed ID: 36421335
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
3. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
4. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
Xiong C; Wang G; Bai D
Bioengineered; 2020 Dec; 11(1):1034-1046. PubMed ID: 32951492
[TBL] [Abstract][Full Text] [Related]
5. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Xu H; Xiong C; Chen Y; Zhang C; Bai D
Bioengineered; 2021 Dec; 12(1):2664-2675. PubMed ID: 34115569
[TBL] [Abstract][Full Text] [Related]
6. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
7. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
[TBL] [Abstract][Full Text] [Related]
8. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
10. Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma.
Liu T; Li ZZ; Sun L; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
BMC Cancer; 2023 Oct; 23(1):1007. PubMed ID: 37858061
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
Jiang W; Wu T; Shi X; Xu J
Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
Tian F; Cai D
Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
[TBL] [Abstract][Full Text] [Related]
14. Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report.
Lü Y; Zhang J; Li L; Li S; Yang Z
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31990034
[TBL] [Abstract][Full Text] [Related]
15. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
Zeng Z; Cao Z; Tang Y
BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma.
Ma X; Ding Y; Zeng L
BMC Cancer; 2021 Apr; 21(1):418. PubMed ID: 33858382
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus‑related hepatocellular carcinoma.
Han Q; Wang X; Liao X; Han C; Yu T; Yang C; Li G; Han B; Huang K; Zhu G; Liu Z; Zhou X; Su H; Shang L; Gong Y; Song X; Peng T; Ye X
Oncol Rep; 2019 Sep; 42(3):895-910. PubMed ID: 31322232
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Dig Dis Sci; 2019 Oct; 64(10):2878-2892. PubMed ID: 30949905
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma.
Zhang Y; Liu X; Liu L; Chen J; Hu Q; Shen S; Zhou Y; Chen S; Xue C; Cui G; Yu Z
Dis Markers; 2020; 2020():2514090. PubMed ID: 32399086
[TBL] [Abstract][Full Text] [Related]
20. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]